Insider Transactions Reported by 19 Insiders of Compass Therapeutics, Inc.

Symbol
CMPX on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Compass Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas J. Schuetz CHIEF EXECUTIVE OFFICER, Director $35,524,123 +$21,100 +0.06% 09 Jan 2026
Vered Bisker-Leib CHIEF EXECUTIVE OFFICER, Director $4,530,418 08 Feb 2024
Barry Shin Cfo $2,714,250 02 Jan 2026
Neil Lerner Chief Accounting Officer $1,977,525 +$28,400 +1.5% 02 Jan 2026
Jonathan Anderman General Counsel $884,070 +$30,800 +3.6% 02 Jan 2026
ORBIMED ADVISORS LLC Director, 10%+ Owner $0 -$5,678,571 -100% 09 Apr 2025
CARL L. GORDON Director $0 -$5,678,571 -100% 02 Jan 2026
Cynthia Sirard Chief Medical Officer 02 Jan 2026
DAVID M. WURZER Director 08 Feb 2023
Ellen Chiniara Director 02 Jan 2026
James P. Boylan Director 02 Jan 2026
Miranda Jayne Toledano Director 25 Jun 2021
RICHARD S. LINDAHL Director 02 Jan 2026
STEPHEN P. SQUINTO Director 18 Feb 2022
Brett Kaplan Director 18 Feb 2022
Philip Ferneau Director 02 Jan 2026
Susan Kalled Chief Scientific Officer 18 Feb 2022
MARY ANN GRAY Director 02 Jan 2026
Arjun Prasad Chief Commercial Officer 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for Compass Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.